Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements.
Créange A, Lefaucheur J-P, Balleyguier M-O, Galactéros F